Earnings Ahead

RMD - ResMed Inc.

210.59 -0.19 -0.09

ResMed Inc.

ResMed Inc.

About

Profile

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for


Headquarters

San Diego, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

RMD

Recent Earnings

ResMed Non-GAAP EPS of $1.66 beats by $0.04, revenue of $1.03B beats by $33.78M



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • ResMed appoints CEO Michael Farrell as chair of the board
  • ResMed Non-GAAP EPS of $1.66 beats by $0.04, revenue of $1.03B beats by $33.78M
  • ResMed Q2 2023 Earnings Preview
  • ResMed shares fall 6% despite reporting FQ1 2023 revenue growth
  • ResMed declares $0.44 dividend
  • ResMed Non-GAAP EPS of $1.51 misses by $0.09, revenue of $950.3M beats by $4.39M
  • ResMed Q1 2023 Earnings Preview
  • ResMed raised to Buy at BofA citing Q1 beat
  • ResMed downgraded at JPMorgan and RBC despite earnings beat
  • ResMed raises dividend by ~5% to $0.44/share
  • ResMed Non-GAAP EPS of $1.49 beats by $0.03, revenue of $914.74M beats by $2.22M
  • ResMed Q4 2022 Earnings Preview
  • ResMed acquires digital insomnia therapy company mementor to bolster sleep portfolio
  • Mehul Joshi joins Berkeley Lights as CFO
  • ResMed to acquire German health software company MediFox for ~$1B
  • ResMed nears $1B deal to buy health software provider MediFox - Bloomberg
  • Amazon, Domino's among additions to BofA's Alpha Surprise screen
  • ResMed goes ex-dividend tomorrow
  • Starbucks, Meta, Exxon among many stocks dropping off BofA's Alpha Surprise screen
  • ResMed Non-GAAP EPS of $1.32 misses by $0.12, revenue of $864.5M misses by $35.53M
Recent Earnings

ResMed Non-GAAP EPS of $1.66 beats by $0.04, revenue of $1.03B beats by $33.78M

Earnings History

Date EPS / Forecast Revenue / Forecast
April 25, 2018 - / - - / 575.8M
January 23, 2018 - / - - / 515.5M
October 26, 2017 - / - - / 473.8M
August 1, 2017 - / - - / 553.9M
April 27, 2017 - / - - / -
January 23, 2017 - / - - / 446.7M
Date Price Open High Low Vol Change ER
Feb 16, 2022 33.220 33.190
33.340
32.800
1.61M 2.18%
Feb 15, 2022 32.510 32.920
32.920
32.150
1.33M -4.63%
Feb 14, 2022 34.090 34.190
34.390
33.840
903.10K 0.74%
Feb 11, 2022 33.840 33.960
34.140
33.820
754.56K -0.76%
Feb 10, 2022 34.100 34.300
34.590
34.100
788.66K 0.71%
 
Feb 9, 2022 33.860 33.850
34.080
33.500
895.59K 1.71%
Feb 8, 2022 33.290 33.160
33.610
33.050
846.10K -0.54%
Feb 7, 2022 33.470 33.570
34.060
33.470
1.18M -0.68%
Feb 4, 2022 33.700 33.470
33.700
33.270
1.24M 1.51%
Feb 3, 2022 33.200 32.930
33.210
32.815
1.31M 1.22%
Feb 2, 2022 32.800 32.630
32.930
32.270
1.15M 0.34%
Feb 1, 2022 32.690 32.450
32.860
32.050
1.31M 2.48%
Jan 31, 2022 31.900 32.480
32.500
31.780
1.63M 2.08%
Jan 28, 2022 31.250 31.510
31.690
30.950
3.92M -0.48%
Jan 27, 2022 31.400 32.570
32.655
31.115
2.41M -3.86%
Jan 25, 2022 32.660 33.200
33.450
32.650
1.73M -0.21%
Jan 24, 2022 32.730 32.680
32.910
32.540
1.03M -0.18%
Jan 21, 2022 32.790 33.000
33.060
32.620
982.63K -1.71%
Jan 20, 2022 33.360 33.410
33.580
33.110
825.18K 0.60%
Jan 19, 2022 33.160 33.570
33.600
33.160
878.79K -4.44%
Jan 18, 2022 34.700 34.740
35.000
34.660
784.09K 0.14%
Jan 17, 2022 34.650 34.790
34.840
34.370
603.86K -0.4%